Sinopharm Group Co. Ltd. (FRA:X2S)

Germany flag Germany · Delayed Price · Currency is EUR
2.259
-0.053 (-2.29%)
Last updated: Feb 20, 2026, 3:31 PM CET
Market Cap7.11B -9.1%
Revenue (ttm)68.67B -3.3%
Net Income847.35M -14.1%
EPS0.27 -13.7%
Shares Outn/a
PE Ratio8.39
Forward PE7.47
Dividend0.08 (3.54%)
Ex-Dividend DateJun 16, 2025
Volume400
Average Volume103
Open2.273
Previous Close2.312
Day's Range2.259 - 2.273
52-Week Range1.934 - 2.554
Betan/a
RSI50.29
Earnings DateMar 27, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 108,217
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol X2S
Full Company Profile

Financial Performance

In 2024, Sinopharm Group's revenue was 584.51 billion, a decrease of -2.02% compared to the previous year's 596.57 billion. Earnings were 7.05 billion, a decrease of -22.14%.

Financial numbers in CNY Financial Statements